Equity-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Stock Option Activity Transactions

The following is a summary of the stock option transactions as of and for the three months ended March 31, 2025:

	Stock Options Outstanding
(amounts in thousands, except shares and per share amount)	Shares Subject to Options Outstanding	Weighted- Average Exercise Price per Option		Weighted- Average Remaining Contractual Terms (in years)	Aggregate Intrinsic Value
Balances as of December 31, 2024	8,762,481	$	16.97	6.29	$	2,250
Options granted	—	—
Options exercised	(24,472)	8.47
Options forfeited / expired	(20,516)	16.06
Balances as of March 31, 2025	8,717,493	17.00		6.04	14,203
Vested and Exercisable as of March 31, 2025	8,238,335	$	17.23	6.01	$	11,551

Schedule of Restricted Stock Transactions

The following is a summary of RSA transactions for the three months ended March 31, 2025:

	Restricted Shares	Weighted-Average Grant Date Fair Value
Unvested and outstanding as of December 31, 2024	50,192	$	16.86
Vested	(49,915)	18.00
Forfeited	(277)	18.00
Unvested and outstanding as of March 31, 2025	—	$	—

The following is a summary of RSU transactions as of and for the three months ended March 31, 2025:

	Restricted Stock Units	Weighted-Average Grant Date Fair Value
Unvested and outstanding as of December 31, 2024	13,344,685	$	9.05
Granted	2,214,287	15.48
Vested(1)	(3,004,707)	6.74
Forfeited	(321,137)	8.71
Unvested and outstanding as of March 31, 2025	12,233,128	$	10.79

(1) Includes shares that vested but the issuance and delivery of the shares was deferred.

Schedule of PSUs Transactions

The following is a summary of PSU transactions for the three months ended March 31, 2025:

	Performance-based restricted stock units	Weighted-Average Grant Date Fair Value
Unvested and outstanding as of December 31, 2024	8,074,871	$	5.64
Granted	714,193	15.50
Vested	(3,826,723)	5.74
Forfeited	(8,334)	5.74
Unvested and outstanding as of March 31, 2025	4,954,007	$	6.98

Schedule of Equity-Based Compensation Expense of Operation

Total equity-based compensation expense was presented on the statement of operations as follows:

	Three Months Ended March 31,
(amounts in thousands)	2025		2024
Selling, general and administrative expenses	$	16,035	$	19,721
Medical expenses	1,152		1,133
Total equity-based compensation expense	$	17,187	$	20,854